Literature DB >> 21159939

False-positive cryptococcal antigen test associated with use of BBL Port-a-Cul transport vials.

Deborah A Wilson1, Mary Sholtis, Sharon Parshall, Gerri S Hall, Gary W Procop.   

Abstract

A total of 52 residual CSF and serum specimens, which were originally negative with the Cryptococcal Antigen Latex Agglutination System (CALAS), were shown to become falsely positive after placement in BBL Port-A-Cul anaerobic transport vials. This transport device, although excellent for specimen transportation for subsequent culture, should not be used if cryptococcal antigen testing is needed.

Mesh：

Substances：

Year:  2010        PMID： 21159939      PMCID： PMC3043472          DOI： 10.1128/JCM.01169-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  False-positive cryptococcal antigen latex agglutination caused by disinfectants and soaps.

Authors:  L B Blevins; J Fenn; H Segal; P Newcomb-Gayman; K C Carroll
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

2.  Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen.

Authors:  T C Wu; S Y Koo
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

3.  Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii.

Authors:  E J McManus; M J Bozdech; J M Jones
Journal:  J Infect Dis       Date:  1985-06       Impact factor: 5.226

4.  New cause for false-positive results with the cryptococcal antigen test by latex agglutination.

Authors:  W H Boom; D J Piper; K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

5.  Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen.

Authors:  L Millon; T Barale; M C Julliot; J Martinez; G Mantion
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

Review 6.  Opportunistic infections of the CNS in patients with AIDS: diagnosis and management.

Authors:  Julio Collazos
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Commercial cryptococcal latex kit: clinical evaluation in a medical center hospital.

Authors:  E Prevost; R Newell
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

8.  Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection.

Authors:  E J McManus; J M Jones
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948
  8 in total
  6 in total

1.  False-positive cerebrospinal fluid cryptococcus antigen in Libman-Sacks endocarditis.

Authors:  Iyad N Isseh; Kassem Bourgi; Asaad Nakhle; Mahmoud Ali; Marcus J Zervos
Journal:  Infection       Date:  2016-05-31       Impact factor: 3.553

Review 2.  New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Authors:  Arthur Jackson; Charles van der Horst
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

3.  Low Cryptococcus Antigen Titers as Determined by Lateral Flow Assay Should Be Interpreted Cautiously in Patients without Prior Diagnosis of Cryptococcal Infection.

Authors:  Marie Dubbels; Dane Granger; Elitza S Theel
Journal:  J Clin Microbiol       Date:  2017-05-31       Impact factor: 5.948

Review 4.  Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Talaromycosis.

Authors:  Daniel B Chastain; Andrés F Henao-Martínez; Carlos Franco-Paredes
Journal:  Curr Infect Dis Rep       Date:  2017-08-22       Impact factor: 3.663

5.  Comment on "cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Int AIDS Soc       Date:  2012       Impact factor: 5.396

6.  Response to comment on "prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda (Oyella et al. 2012)".

Authors:  Jacinta Oyella; David Meya; Francis Bajunirwe; Moses R Kamya
Journal:  J Int AIDS Soc       Date:  2012       Impact factor: 5.396
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.